Anti-(human Growth Differentiation Factor 8) (human Clone Bms-986089 Fibronectin Tenth Type Iii Domain-derived)

Anti-(human Growth Differentiation Factor 8) (human Clone Bms-986089 Fibronectin Tenth Type Iii Domain-derived) Uses, Dosage, Side Effects, Food Interaction and all others data.

Anti-(human Growth Differentiation Factor 8) (human Clone Bms-986089 Fibronectin Tenth Type Iii Domain-derived) is under investigation in clinical trial NCT03039686 (Clinical Trial to Evaluate the Efficacy, Safety, and Tolerability of RO7239361 in Ambulatory Boys With Duchenne Muscular Dystrophy).

Trade Name Anti-(human Growth Differentiation Factor 8) (human Clone Bms-986089 Fibronectin Tenth Type Iii Domain-derived)
Generic Talditercept alfa
Talditercept alfa Other Names Adnectin, anti-(human growth differentiation factor 8) (synthetic clone prd-1474 fibronectin type iii tenth domain (10fn3)-based isoform, Bms-986089 (fully human anti-myostatin adnectin), Immunoglobulin g1 (human fc fragment) fusion protein with peptide (synthetic 17-amino acid linker) fusion protein with adnectin, anti-(human growth differentiation factor 8) (human clone bms-986089 fibronectin tenth type iii domain-derived), dimer, Taldefgrobep alfa, Talditercept alfa
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Anti-(human Growth Differentiation Factor 8) (human Clone Bms-986089 Fibronectin Tenth Type Iii Domain-derived)
Anti-(human Growth Differentiation Factor 8) (human Clone Bms-986089 Fibronectin Tenth Type Iii Domain-derived)

*** Taking medicines without doctor's advice can cause long-term problems.
Share